ERAS
Erasca, Inc.
NASDAQ · Healthcare · Biotechnology · US
$16.09
−1.03%Leverage
- Debt / equity
- 0.12x
- Net debt / equity
- 0.01x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -0.16x
- Net debt / EBITDA
- -0.01x
Liquidity & coverage
- Current ratio
- 8.29x
- Quick ratio
- 8.29x
- Cash ratio
- 8.01x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $244.9M
Cash & dividend
- FCF / debt
- -2.19x
- Cash flow / debt
- -2.19x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026